GLORIA MELANIE (Chief Operating Officer) received a stock award from IMMUNOVANT, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/9/2026ACC: 0001764013-26-000040
Officer· Chief Operating Officer
Since Feb 2026
+204.73K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
204.73K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+83.67K
Price / share
—
Trade value
—
% of position
49.1%
4/7/2026
170.27K→253.94K
Total
Net shares
+83.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/7/2026 | A · Award | +83.67K | — | — | 49.1% | 170.27K | 253.94K |
| Total | +83.67K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
121.06K shares
Shares
+121.06K
Strike price
24.61
Held after
121.06K
Exercisable
—
4/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock121.06K shares | 4/7/2026 | A · Award | +121.06K | 24.61 | — | 121.06K |